FOOD AND DRUG ADMINISTRATION (FDA) 
Center for Drug Evaluation and Research (CDER) 

Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC) Meeting 

College Park Marriott Hotel & Conference Center, Potomac Ballroom 

3501 University Blvd. East, Hyattsville, Maryland 

 

 

 
 

January 12, 2015 

MEETING ROSTER 

 Diana Hallare, MPH  
(Consumer Representative) 
Visalia, California 
 

Susan R. Heckbert, MD, PhD 
Professor 
Department of Epidemiology 
University of Washington 
Seattle, Washington 
 

William R. Hiatt, MD, FACP, FAHA 
Professor of Medicine  
Division of Cardiology 
University of Colorado School of Medicine  
President, Colorado Prevention Center  (CPC) 
Clinical Research 
Aurora, Colorado  
 
 

Page 1 of 3 

DESIGNATED FEDERAL OFFICER (Non-Voting) 
 
Stephanie L. Begansky, PharmD  
Division of Advisory Committee and Consultant Management 
Office of Executive Programs, CDER, FDA 
 
ENDOCRINOLOGIC AND METABOLIC DRUGS ADVISORY COMMITTEE MEMBERS 
(Voting) 
 
Brendan M. Everett, MD, MPH 
Assistant Professor of Medicine 
Harvard Medical School 
Director, General Cardiology Inpatient Service, 
Brigham and Womenâ€™s Hospital 
Boston, Massachusetts 
 

James D. Neaton, PhD 
Professor of Biostatistics 
Division of Biostatistics 
Coordinating Centers for Biometric Research 
School of Public Health 
University of Minnesota 
Minneapolis, Minnesota 
 
Robert J. Smith, MD 
(Chairperson) 
Professor of Medicine (Endocrinology) 
Alpert Medical School of Brown University 
Ocean State Research Institute 
Providence Veterans Administration (VA) Medical 
Center 
Providence, Rhode Island 
 
Peter W. F. Wilson, MD 
Director, Epidemiology and Genomic Medicine 
Atlanta Veterans Administration Medical Center 
Professor of Medicine and Public Health 
Emory University 
Emory Clinical Cardiovascular Research Institute 
Atlanta, Georgia  
 

FOOD AND DRUG ADMINISTRATION (FDA) 
Center for Drug Evaluation and Research (CDER) 

Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC) Meeting 

January 12, 2015 

MEETING ROSTER (cont.) 

 

 

 

 

 

 
ENDOCRINOLOGIC AND METABOLIC DRUG PRODUCTS ADVISORY COMMITTEE 
MEMBER (Non-Voting) 
 
Mads F. Rasmussen, MD, PhD 
(Industry Representative) 
Project Vice President 
GLP-1 and Obesity 
Global Development 
Novo Nordisk A/S 
Denmark 
 
TEMPORARY MEMBERS (Voting) 
 
Stuart S. Howards, MD 
Diane M. Biskobing, MD 
Professor of Medicine 
Professor of Urology  
Program Director, Endocrinology and Metabolism  University of Virginia  
Fellowship 
Charlottesville, Virginia 
Wake Forest Medical School  
Virginia Commonwealth School of Medicine 
Winston Salem, North Carolina 
Richmond, Virginia 
 
Daniel Budnitz, MD, MPH 
CAPT, US Public Health Service 
Director, Medication Safety Program 
Division of Healthcare Quality Promotion 
Centers for Disease Control and Prevention 
Atlanta, Georgia 
 
Toby C. Chai, MD 
Professor of Urology 
Vice Chair of Research 
Department of Urology 
Yale School of Medicine 
Co-Director of FPMRS Program  
Yale-New Haven Hospital 
New Haven, Connecticut 
 
Jonathan Emens, MD 
Associate Professor, Department of Psychiatry 
Assistant Professor, Department of Medicine 
Oregon Health & Science University 
Sleep Lab Director and Staff Physician 
VA Portland Health Care System 
Portland, Oregon 
 
 

Kevin D. McBryde, MD 
Program Director 
Office of Minority Health and Research 
Coordination 
National Institute of Diabetes, Digestive, and  
Kidney Diseases, NIH 
Bethesda, Maryland 

John Lavelle, MD 
Associate Professor of Urology 
Stanford University 
Staff Physician 
Veterans Affairs Hospital 
Palo Alto, California 

Shirley Miller 
(Patient Representative) 
Charlotte, North Carolina 
 

Page 2 of 3 

FOOD AND DRUG ADMINISTRATION (FDA) 
Center for Drug Evaluation and Research (CDER) 

Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC) Meeting 

January 12, 2015 

MEETING ROSTER (cont.) 

 

 

 

 

 
TEMPORARY MEMBERS (Voting) (cont.) 
 
Martha Nason, PhD 
Mathematical Statistician 
Biostatistics Research Branch, Division of 
Clinical Research 
National Institute of Allergy and Infectious 
Diseases, National Institutes of Health (NIH) 
Bethesda, Maryland 
 
FDA PARTICIPANTS (Non-Voting) 
 
Jean-Marc Guettier, MD 
Director, Division of Metabolism and 
Endocrinology Products (DMEP) 
Office of Drug Evaluation (ODE) II 
Office of New Drugs (OND), CDER, FDA 
  
William Lubas, MD, PhD 
Medical Officer 
DMEP, ODE II, OND, CDER, FDA 
 
 

Christian Pavlovich, MD 
Associate Professor, Urology 
James Buchanan Brady Urological Institute 
Johns Hopkins University School of Medicine 
Baltimore, Maryland 
 

Mark Hirsch, MD 
Medical Team Leader in Urology 
Division of Bone, Reproductive and Urologic 
Products (DBRUP) 
ODE III, OND, CDER, FDA  

Roger Wiederhorn, MD 
Medical Officer 
DBRUP, ODE III, OND, CDER, FDA 
 

Page 3 of 3 

